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1. Introduction 
In bacteria many examples of the participation of 
long-chain polyprenols as lipid carriers of carbohydrate 
units in the biosynthesis of complex polysaccharides 
are known [ 11; a “lipid intermediate” is formed, in 
which a carbohydrate residue is linked to a polyprenol 
residue through a mono- or pyrophosphate bridge. In 
the biosynthesis of yeast mannan, a similar mechanism 
appears to operate [2,3] and the active lipid is prob- 
ably dolichol; yeast dolichol is a mixture of very long- 
chain polyprenols, differing slightly in chain-length 
from mammalian dolichols [4], in which the main 
isomer is Cg, . Recently, similar glycolipids, in which 
the lipid is either dolichol or a very similar compound, 
and where the carbohydrate being transferred is 
D-mannose [S-9], have been discovered as products 
of microsomal systems derived from a variety of animal 
tissues. The mannolipids have only been obtained in 
very small quantities, and this has made structural in- 
vestigations difficult to perform. However, there are 
strong indications that the sugar is linked to the lipid 
through a monophosphate bridge. In an attempt to 
obtain definitive proof of the structure of the com- 
pound formed by pig-liver endoplasmic reticulum [lo], 
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we have performed a chemical synthesis of a-D-manno- 
pyranosyl dolichyl phosphate by the DCC mediated 
condensation of dolichol with fully acetylated 
a-D-mannopyranosyl phosphate and subsequent 
deacylation of the product (scheme 1). The detailed 
comparison of the naturally formed and synthetic 
mannolipids is reported in the accompanying paper 
[lOI. 
2. Materials and methods 
Dolichol [2], isolated from pig liver, was a gift from 
Dr. F.W. Hemming. 2,3,4,6-Tetra-O-acetyl-cy-D-manno- 
pyranosyl phosphate [l] was prepared from 1,2,3,4,6- 
penta-O-acetyl-ct$-D-mannopyranose, by a method 
[ 1 l] similar to that reported for the preparation of 
the D-galactose derivative [ 121. The conditions for 
phosphodiester formation were similar to those used by 
Cawly and Letters [ 131. Dicyclohexylcarbodiimide 
(DCC) was obtained from Eastman-Kodak, Rochester, 
N.Y. 14650. 
Optical rotations were determined in 1-dm semi- 
micro tubes with a Perkin-Elmer Model 14 1 polari- 
meter. Infrared spectra were recorded with a Perkin- 
Elmer spectrophotometer, Model 237. Evaporations 
were carried out under reduced pressure, with an out- 
side bath temp. kept below 30”. 
Column chromatography was performed on Silica 
Gel 0.05-0.2 mm (70-325 mesh, E. Merck A.G., 
Darmstadt, Germany; the material was used without 
pretreatment). Thin-layer chromatography (TLC) was 
performed on precoated plates of Silica Gel G (Merck); 
North-Holland Illblishing Company - Amsterdam 
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the plates were cut to a length of 6 cm before use, 
otherwise they were used without pretreatment. Pre- 
parative TLC was carried out on precoated PLC plates, 
Silica Gel F 254 (Merck). The spots were detected 
with the anisaldehyde spray reagent [ 141 (a), the 
potassium permanganate spray reagent [ 151 (b), and 
the phosphate-specific spray reagent [ 161 (c). Solvents 
A, B and C were chloroform-methanol-water 
(60:25:4), (60:35:6) and (10: 10:3), respectively, 
solvent D was 2,6-dimethyl-4-heptanone-acetic acid- 
water (20: 15:2) and solvent E was 2-propanol-I 5 M 
ammonium hydroxide-water (6:3: 1). 
3. Results and discussion 
A mixture of (2) (28 mg) and (1) (pyridinium 
form, 4 mg) was treated with DCC (20 mg). In order 
to remove traces of water, toluene (2 ml) was added 
to the mixture, and then evaporated, and this proce- 
dure was repeated three times. The anhydrous mixture 
was treated with dry pyridine (1 ml, kept for several 
days over calcium hydride) and stirred for 24 hr; 
additional amounts of DCC (20 mg) and (1) (4 mg) 
were added after 24 and 48 hr for a total reaction 
time of 72 hr. (The repeated addition and evaporation 
of toluene, followed by addition of dry pyridine as 
solvent was performed after each addition). The sol- 
vent was evaporated and the residue dissolved in 
chloroform (1 ml). TLC (a) indicated that more than 
50% of the dolichol had been converted into (3). 
Column chromatography on silica gel (3.0 g) was per- 
formed with mixtures of chloroform and methanol, 
the proportion of methanol being gradually increased 
from (50: l), which eluted unchanged dolichol with 
some DCC and dicyclohexylurea, to (10: 1) which 
eluted 2,3,4,6-tetra-O-acetyl-CY-D-mannopyranosyl 
dolichyl phosphate (3, pyridinium form, 21 mg). This 
material was deacylated in chloroform (0.5 ml) by 
treatment with 1% sodium methoxide in abs. 
methanol (0.5 ml). After 30 min TLC (solvent A, a) 
showed the formation of a new product, (Rf 0.54). 
Another substance, (Rf 0.8), with the same mobility 
as (3), was apparently a contaminant, as it was un- 
affected by a prolonged treatment with excess base. 
The reaction mixture was evaporated to ca. 0.2 ml and 
a few drops of chloroform added to give a clear solu- 
tion. This was applied to a preparative TLC plate 
(20 cm X 5 cm) and eluted with solvent B. The band 
containing the compound (4) was located by spraying 
a narrow area near the center of the plate with(b) and 
(c), and the compound was extracted with solvent C. 
Evaporation of the solution gave syrupy cr-D-manno- 
pyranosyl dolichyl phosphate (4, 12 mg, sodium salt), 
[al fjo + 3.5” (c 0.8, chloroform-methanol, 5: 1). It 
was pure on TLC in solvents A, B, D and E (a,b,c); the 
IR spectrum showed absorption maxima which were 
consistent with the expected structure: vrnaX film 3350 
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(very broad, OH), 2965 (CH, stretching), 2930 and 
2860 (CH, stretching), 1730 (unassigned - also present 
in dolichyl phosphate [ 171) 1660 (C=C stretching), 
1450 (CH,, -CH,), 1376 (-CH3), 1220 (F’=O), 1070 
(C-O- stretching, adjacent to a saturated isoprene 
residue), 975 and 835 cm-l (-CH=C:); the NMR 
spectrum also showed most of the expected signals, and 
is given in the accompanying paper [lo]. 
A small sample of the product (1 mg) was subjected 
to dilute acid hydrolysis with 0.5 ml of a mixture of 
M hydrochloric acid and methanol (1: 10). Chloroform 
(approx. 0.2 ml) was added until a clear solution was 
obtained, which was then kept at 100” for 5 min in a 
sealed tube. Examination of the solution by TLC (a) 
showed the presence of only one substance derived 
from dolichol (an intense violet-blue spot) which co- 
chromatographed with dolichyl phosphate [ 171: Rf 
0.63 (solvent A) and 0.76 (solvent D). The other 
products were D-mannose (Rf 0.27) and methyl man- 
noside (Rf 0.43, Rf 0.55 and Rf 0.61) (solvent B), 
all of which gave a green spot. 
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